0008-1041 : Rapamune 1 mg Oral Tablet
NDC: | 0008-1041 |
Labeler: | Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Rapamune |
Dosage Form: | Oral Tablet, Sugar Coated |
Application #: | NDA021110 |
Rev. Date: |
Appearance:
Markings: | RAPAMUNE;1;MG |
Shapes: |
Triangle (3 sides) |
Colors: |
White |
Size (mm): | 8 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0008-1041-05: 100 TABLET, SUGAR COATED IN 1 BOTTLE (0008‑1041‑05)
- 0008-1041-10: 100 BLISTER PACK IN 1 CARTON (0008‑1041‑10) > 1 TABLET, SUGAR COATED IN 1 BLISTER PACK
Active Ingredients:
- Sirolimus
Dosage Strength:
- 1 mg
Inactive Ingredients:
- Sucrose
- Polyethylene Glycol 8000
- Calcium Sulfate
- Cellulose, Microcrystalline
- Talc
- Titanium Dioxide
- Magnesium Stearate
- Povidone K29/32
- Lactose Monohydrate
- Poloxamer 188
- Carnauba Wax
- .alpha.-tocopherol Acetate
- Glyceryl Oleate
Pharmaceutical Classes:
- Decreased Immunologic Activity [PE]
- Kinase Inhibitor [EPC]
- Protein Kinase Inhibitors [MoA]
- mTOR Inhibitor Immunosuppressant [EPC]
- mTOR Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0008-1030 Rapamune 1 mg/ml Oral Solution by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
- 0008-1040 Rapamune 0.5 mg Oral Tablet by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
- 0008-1042 Rapamune 2 mg Oral Tablet by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
- 55154-4227 Rapamune 1 mg Oral Tablet by Cardinal Health
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0008-1040Next: 0008-1042 >
Related Discussions:
sirolimus and eye sight
How does sirolimus effect your eyesight...
How does sirolimus effect your eyesight...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.